| Matrix metallopeptidase 12 (Mmp12)
|
1.00±0.10 |
285.41±3.65 |
290.41±4.66 |
| Ring finger protein 128 (Rnf128)
|
1.00±0.14 |
54.84±3.88 |
47.33±0.52 |
| Glycoprotein (transmembrane) nmb (Gpnmb)
|
1.00±0.11 |
27.90±2.54 |
34.98±1.38 |
| Interleukin 7 receptor (Il7r)
|
1.00±0.04 |
26.89±0.74 |
46.29±0.97 |
| Glutaminyl-peptide cyclotransferase (glutaminyl cyclase) (Qpct)
|
1.00±0.29 |
26.43±1.09 |
24.24±2.09 |
| Lipoprotein lipase (Lpl)
|
1.00±0.04 |
24.77±0.50 |
27.07±0.23 |
| V-set and immunoglobulin domain containing 8 (Vsig8)
|
1.00±0.07 |
24.16±1.25 |
28.75±0.25 |
| Fibroblast growth factor 13 (Fgf13)
|
1.00±0.29 |
20.66±0.77 |
12.73±0.46 |
| Coagulation factor VII (F7)
|
1.00±0.10 |
20.29±1.21 |
41.00±0.24 |
| Cathepsin K, (Ctsk)
|
1.00±0.04 |
20.17±0.30 |
19.93±0.93 |
|
Upregulated in Sal mice relative to NC mice
|
|
Genes
|
NC
|
HFD
|
Sal
|
| Matrix metallopeptidase 12 (Mmp12)
|
1.00±0.10 |
285.41±3.65 |
290.41±4.66 |
| Ring finger protein 128 (Rnf128)
|
1.00±0.14 |
54.84±3.88 |
47.33±0.52 |
| Interleukin 7 receptor (Il7r)
|
1.00±0.04 |
26.89±0.74 |
46.29±0.97 |
| Coagulation factor VII (F7)
|
1.00±0.10 |
20.29±1.21 |
41.00±0.24 |
| Glycoprotein (transmembrane) nmb (Gpnmb)
|
1.00±0.11 |
27.90±2.54 |
34.98±1.38 |
| V-set and immunoglobulin domain containing 8 (Vsig8)
|
1.00±0.07 |
24.16±1.25 |
28.75±0.25 |
| Lipoprotein lipase (Lpl)
|
1.00±0.04 |
24.77±0.50 |
27.07±0.23 |
| Glutaminyl-peptide cyclotransferase (glutaminyl cyclase) (Qpct)
|
1.00±0.29 |
26.43±1.09 |
24.24±2.09 |
| Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 (Kcnn4)
|
1.00±0.03 |
16.11±0.50 |
22.18±0.30 |
| Protocadherin 7 (Pcdh7)
|
1.00±0.07 |
18.41±2.66 |
21.32±1.68 |
|
Upregulated in Sal mice relative to HFD mice
|
|
Genes
|
NC
|
HFD
|
Sal
|
| immunoglobulin lambda chain, constant region 3 (Igl-C3)
|
1.16±0.05 |
1.00±0.04 |
6.45±0.49 |
| Dedicator of cytokinesis 7 (Dock7)
|
0.82±0.29 |
1.00±0.29 |
4.23±0.56 |
| Kinesin family member 13B (Kif13b)
|
0.86±0.05 |
1.00±0.02 |
4.16±0.36 |
| Immunoglobulin lambda chain, constant region 2 (Igl-C2)
|
0.15±0.04 |
1.00±0.04 |
3.38±0.11 |
| NFκB inhibitorξ (Nfkbiz)
|
0.96±0.01 |
1.00±0.09 |
3.04±0.03 |
| Forkhead box P1 (Foxp1)
|
1.83±0.23 |
1.00±0.02 |
2.99±0.26 |
| Eosinophil-associated, ribonuclease A family (Ear)
|
0.34±0.00 |
1.00±0.00 |
2.97±0.13 |
| Lactate dehydrogenase C (Ldhc)
|
0.96±0.00 |
1.00±0.05 |
2.94±0.37 |
| Acyl-Coenzyme A binding domain containing 3 (Acbd3)
|
1.50±0.04 |
1.00±0.03 |
2.90±0.14 |
| Cut-like homeobox 1 (Cux1)
|
2.02±0.00 |
1.00±0.05 |
2.90±0.20 |
|
Downregulated in HFD mice relative to NC mice
|
|
Genes
|
NC
|
HFD
|
Sal
|
| Aldo-keto reductase family 1, member B7 (Akr1b7)
|
1.00±0.12 |
0.02±0.00 |
0.01±0.00 |
| Protamine 1 (Prm1)
|
1.00±0.06 |
0.02±0.00 |
0.02±0.00 |
| Dysteine-rich secretory protein 1 (Crisp1)
|
1.00±0.02 |
0.03±0.00 |
0.02±0.00 |
| Clusterin (Clu)
|
1.00±0.06 |
0.03±0.00 |
0.04±0.00 |
| Carboxylesterase 3 (Ces3)
|
1.00±0.06 |
0.03±0.00 |
0.04±0.00 |
| Complement factor D (adipsin) (Cfd)
|
1.00±0.08 |
0.04±0.00 |
0.04±0.00 |
| Uroplakin 3B (Upk3b)
|
1.00±0.07 |
0.04±0.00 |
0.07±0.00 |
| Uroplakin 1B (Upk1b)
|
1.00±0.07 |
0.05±0.00 |
0.05±0.00 |
| Keratin 8 (Krt8)
|
1.00±0.20 |
0.05±0.00 |
0.06±0.00 |
| Carbonic anhydrase 3 (Car3)
|
1.00±0.03 |
0.06±0.00 |
0.40±0.00 |
|
Downregulated in Sal mice relative to NC mice
|
|
Genes
|
NC
|
HFD
|
Sal
|
| Aldo-keto reductase family 1, member B7 (Akr1b7)
|
1.00±0.12 |
0.02±0.00 |
0.01±0.00 |
| Cysteine-rich secretory protein 1 (Crisp1)
|
1.00±0.02 |
0.03±0.00 |
0.02±0.00 |
| Selectin, platelet (Selp)
|
1.00±0.03 |
0.10±0.01 |
0.02±0.00 |
| Protamine 1 (Prm1)
|
1.00±0.06 |
0.02±0.00 |
0.02±0.00 |
| Serum amyloid A 3 (Saa3)
|
1.00±0.01 |
0.17±0.00 |
0.04±0.00 |
| Complement factor D (adipsin) (Cfd)
|
1.00±0.08 |
0.04±0.00 |
0.04±0.00 |
| Clusterin (Clu)
|
1.00±0.06 |
0.03±0.00 |
0.04±0.00 |
| Carboxylesterase 3 (Ces3)
|
1.00±0.06 |
0.03±0.00 |
0.04±0.00 |
| Uroplakin 1B (Upk1b)
|
1.00±0.07 |
0.05±0.00 |
0.05±0.00 |
| Histidine decarboxylase, (Hdc)
|
1.00±0.02 |
0.16±0.00 |
0.05±0.00 |
|
Downregulated in Sal mice relative to HFD mice
|
|
Genes
|
NC
|
HFD
|
Sal
|
| Igκ chain variable 28 (Igk-V28)
|
0.16±0.01 |
1.00±0.06 |
0.12±0.01 |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 21 (Nudt21)
|
0.16±0.15 |
1.00±0.01 |
0.13±0.01 |
| Fascin homolog 1, actin bundling protein (Fscn1)
|
0.88±0.02 |
1.00±0.07 |
0.18±0.03 |
| Cytoplasmic polyadenylation element binding protein 2, Cpeb2 |
1.34±0.21 |
1.00±0.06 |
0.19±0.01 |
| CD5 antigen-like (Cd5l)
|
0.51±0.02 |
1.00±0.04 |
0.20±0.02 |
| GC-rich promoter binding protein 1 (Gpbp1)
|
1.68±0.29 |
1.00±0.06 |
0.20±0.05 |
| Serum amyloid A 3 (Saa3)
|
5.84±0.03 |
1.00±0.00 |
0.21±0.01 |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 21 (Nudt21)
|
0.60±0.07 |
1.00±0.11 |
0.22±0.00 |
| Selectin, platelet (Selp)
|
10.06±0.27 |
1.00±0.08 |
0.23±0.02 |
| Selenoprotein W, muscle 1 (Sepw1)
|
3.07±0.47 |
1.00±0.02 |
0.25±0.00 |
